SAN JOSE, Calif., July 28 /PRNewswire-FirstCall/ -- VNUS(R) Medical
Technologies, Inc. (Nasdaq: VNUS), a leading provider of medical devices for
the minimally invasive treatment of venous reflux disease, today announced its
plans to present at the BMO Capital Markets 2008 Focus on Healthcare
Conference, to be held August 5-6, 2008, at the Millennium Broadway Hotel in
New York City.
VNUS' presentation is currently scheduled for 10:00 a.m. ET on Wednesday,
August 6, and will be webcast on the corporate website at
http://ir.vnus.com/events.cfm. The management speakers will be Brian Farley,
President and Chief Executive Officer, and Peter Osborne, Chief Financial
Officer and Vice President of Finance and Administration. An archive of the
webcast will be available through August 6, 2009.
About VNUS Medical Technologies, Inc.
VNUS is a leading provider of medical devices for the minimally invasive
treatment of venous reflux disease, a progressive condition that is often the
underlying cause of painful varicose veins. VNUS sells the Closure(R) system,
which consists of a proprietary radiofrequency (RF) generator and proprietary
disposable endovenous catheters and devices to close diseased veins through
the application of temperature-controlled RF energy. Approximately
300,000 patients have been treated to date with VNUS Closure catheters. For
more information, please visit the corporate website at http://www.vnus.com .
SOURCE VNUS Medical Technologies, Inc.